Abstract:Aggregation and cytotoxicity of Aβ with redox-active metals in neuronal cells have been implicated in the progression of Alzheimer disease. Human metallothionein (MT) 3 is highly expressed in the normal human brain and is downregulated in Alzheimer disease. Zn7MT3 can protect against the neuronal toxicity of Aβ by preventing copper-mediated Aβ aggregation, abolishing the production of reactive oxygen species (ROS) and the related cellular toxicity. In this study, we intended to decipher the roles of single-domain proteins (α/β) and the α–β domain–domain interaction of Zn7MT3 to determine the molecular mechanism for protection against the neuronal cytotoxicity of Aβ1–42 with copper ions. With this in mind, the α and β single-domain proteins, heterozygous β(MT3)–α(MT1), and a linker-truncated mutant ∆31–34 were prepared and characterized. In the presence/absence of various Zn7MT3 proteins, the Aβ1–42–Cu2+-mediated aggregation, the production of ROS, and the cellular toxicity were investigated by transmission electron microscopy, ROS assay by means of a fluorescent probe, and SH-SY5Y cell viability, respectively. The β domain cannot abolish Aβ1–42–Cu2+-induced aggregation, and neither the β domain nor the α domain can quench the production of ROS because of the redox cycling of Aβ–Cu2+. Similarly to wild-type Zn7MT3, the heterozygous β(MT3)–α(MT1) possesses the characteristic of alleviating Aβ1–42 aggregation and oxidative stress to neuronal cells. Therefore, the two domains through the linker Lys-Lys-Ser form a cooperative unit, and each of them is indispensable in conducting its bioactivity. The α domain plays an important role in modulating the stability of the metal–thiolate cluster, and the α–β domain–domain interaction through the linker is critical for its protective role in the brain.

Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3.

Effect of α-domain substitution on the structure, property and function of human neuronal growth inhibitory factor

The Study of Human Growth Inhibitory Factor E58K and E55/58/60Q Mutants

Altered Expression of Zinc Finger Proteins, ADAMs, and Integrin‐related Proteins Following Treatment of Cultured Human Cells with a Low Concentration of N‐methyl‐N′‐nitro‐N‐nitrosoguanidine

Solution Structure and Dynamics of Human Metallothionein-3 (Mt-3)

The Effect of the EAAEAE Insert on the Property of Human Metallothionein-3.

The Molecular Mechanism for Human Metallothionein-3 to Protect Against the Neuronal Cytotoxicity of Aβ1–42 with Cu Ions

Mammalian Metallothionein-3: New Functional and Structural Insights

The Effect of Nitric Oxide on Metal Release from Metallothionein-3: Gradual Unfolding of the Protein

TheΔ33-35 Mutantα-Domain Containingβ-Domain-LikeM3S

Important Roles of the Conserved Linker-Kks in Human Neuronal Growth Inhibitory Factor

The Δ33-35 Mutant α-Domain Containing β-Domain-Like M3S9 Cluster Exhibits the Function of α-Domain with M4S11 Cluster in Human Growth Inhibitory Factor

Study on structure-property-reactivity-function relationship of human neuronal growth inhibitory factor (hGIF).

An Insight of S‐Nitrosylation of Human GIF

[Affection of Metallothionein-3 to Dutpase's Accommodating Cellular Toxicity of Dutp].

High level expression , efficient purification , and bioactivity of recombinant human metallothionein 3 ( rhMT 3 ) from methylotrophic yeast

Effect of mutation of Cys33 and Cys34 in the alpha-domain of monkey metallothionein-1 on the protein stability

Metallothioneins protect cytosolic creatine kinases against stress induced by nitrogen-based oxidants.

Neuronal Growth-Inhibitory Factor (Metallothionein-3): Structure-Function Relationships

The Structural and Biological Significance of the EAAEAE Insert in the Α‐domain of Human Neuronal Growth Inhibitory Factor

Expression, Characterization, and Reaction of Recombinant Monkey Metallothionein-1 and Its C33M Mutant